97822706 - TOUCAN

Information

  • Trademark
  • 97822706
  • Serial Number
    97822706
  • Filing Date
    March 03, 2023
    a year ago
  • Transaction Date
    April 01, 2024
    9 months ago
  • Status Date
    April 01, 2024
    9 months ago
  • Location Date
    April 01, 2024
    9 months ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    SINGER, MELANIE ALYSSA
  • Attorney Docket Number
    60895-576596
    Attorney Name
    Rebecca Liebowitz
    Law Office Assigned Location Code
    M30
  • Owners
Mark Drawing Code
4000
Mark Identification
TOUCAN
Case File Statements
  • GS0401: Treatment of nucleic acid constructs; manufacture of nucleic acid constructs; manufacture of nucleic acids; manufacture of viruses; manufacture of vectors; manufacture of medical and veterinary therapies, vaccines, prophylactics and counteragents; consultancy relating to the aforesaid services
  • GS0091: Apparatus and instruments for the manufacture and processing of nucleic acid constructs
  • GS0051: Nucleic acid constructs for medical and veterinary purposes; nucleic acid constructs and vectors for use as prophylactic or therapeutic vaccines; nucleic acid constructs and vectors for the production of prophylactic or therapeutic vaccines; nucleic acid constructs and vectors for medical use; nucleic acid constructs and vectors for the production of therapeutic or prophylactic viruses; nucleic acid constructs and vectors for gene therapy; nucleic acid constructs and vectors for use in cell therapy; nucleic acid constructs and vectors for use in genome editing; nucleic acid constructs and vectors for use in therapy
  • GS0011: Chemicals, enzymes, nucleic acid constructs and vectors for scientific and research use; nucleic acid constructs and vectors for use in the manufacture of nucleic acids; nucleic acid constructs and vectors for manufacturing viruses; nucleic acid constructs and vectors for use in scientific research
  • GS0421: Scientific and technological services and research and design relating thereto; chemical and biological analysis and research services; research into nucleic acids and nucleic acid constructs; research and development into the creation of nucleic acid constructs; research, analysis, design and development relating to therapies, prophylactics and counteragents based on nucleic acid constructs; research and development in the fields of gene therapy and diagnostics; consultancy relating to the aforesaid services
Case File Event Statements
  • 4/1/2024 - 9 months ago
    11 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 4/1/2024 - 9 months ago
    10 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 12/7/2023 - a year ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/7/2023 - a year ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/7/2023 - a year ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/1/2023 - a year ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/13/2023 - a year ago
    5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 11/13/2023 - a year ago
    4 - ASSIGNED TO LIE Type: ALIE
  • 6/8/2023 - a year ago
    3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 3/23/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/7/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP